WMSA
TMCI icon

Weiss Multi-Strategy Advisers’s Treace Medical Concepts TMCI Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,000
Closed -$255K – 436
2023
Q4 		$255K Buy
+20,000
New +$202K 0.01% 501

Other funds holding TMCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TMCI Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Treace Medical Concepts (TMCI) in Q1 2024, closing a stake of 20,000 shares — an estimated $255K sold.

Weiss Multi-Strategy Advisers first reported a position in TMCI in Q4 2023 and held it in 1 quarter. The position peaked at $255K in Q4 2023. 132 funds tracked by Wall St. Rank hold TMCI as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Treace Medical Concepts position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 20,000 Treace Medical Concepts shares in Q1 2024, an estimated $255K.
  • Weiss Multi-Strategy Advisers first reported a position in Treace Medical Concepts in Q4 2023 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Treace Medical Concepts position peaked at $255K in Q4 2023.
  • 132 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.